Zhang X, Yu X
Front Pharmacol. 2023; 14:1230822.
PMID: 37601042
PMC: 10433774.
DOI: 10.3389/fphar.2023.1230822.
Chen Y, Tan S, Fu J
J Mol Evol. 2022; 90(5):389-399.
PMID: 36029325
DOI: 10.1007/s00239-022-10070-4.
Catalano T, DAmico E, Moscatello C, Di Marcantonio M, Ferrone A, Bologna G
Cancers (Basel). 2021; 13(23).
PMID: 34885156
PMC: 8656656.
DOI: 10.3390/cancers13236045.
Huang T, Peng K, Kuo T, Lin L, Liu B, Ye S
Biomedicines. 2021; 9(8).
PMID: 34440086
PMC: 8389646.
DOI: 10.3390/biomedicines9080882.
Noe O, Filipiak L, Royfman R, Campbell A, Lin L, Hamouda D
Oncol Rev. 2021; 15(1):534.
PMID: 34267890
PMC: 8256374.
DOI: 10.4081/oncol.2021.534.
Loss of Aryl Hydrocarbon Receptor Promotes Colon Tumorigenesis in Mice.
Han H, Davidson L, Hensel M, Yoon G, Landrock K, Allred C
Mol Cancer Res. 2021; 19(5):771-783.
PMID: 33495399
PMC: 8137548.
DOI: 10.1158/1541-7786.MCR-20-0789.
Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
Kim Y, Wojtowicz D, Sarto Basso R, Sason I, Robinson W, Hochbaum D
Genome Med. 2020; 12(1):52.
PMID: 32471470
PMC: 7260830.
DOI: 10.1186/s13073-020-00745-2.
Molecular Aspects of Colorectal Adenomas: The Interplay among Microenvironment, Oxidative Stress, and Predisposition.
Aceto G, Catalano T, Curia M
Biomed Res Int. 2020; 2020:1726309.
PMID: 32258104
PMC: 7102468.
DOI: 10.1155/2020/1726309.
The splicing component ISY1 regulates APE1 in base excision repair.
Jaiswal A, Williamson E, Srinivasan G, Kong K, Lomelino C, McKenna R
DNA Repair (Amst). 2019; 86:102769.
PMID: 31887540
PMC: 7185567.
DOI: 10.1016/j.dnarep.2019.102769.
APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells.
Stefanski C, Keffler K, McClintock S, Milac L, Prosperi J
Neoplasia. 2019; 21(12):1143-1150.
PMID: 31759252
PMC: 6872841.
DOI: 10.1016/j.neo.2019.09.002.
Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing.
Abdul S, Mutalib N, Sean K, Syafruddin S, Ishak M, Sagap I
Front Pharmacol. 2017; 8:465.
PMID: 28769798
PMC: 5513919.
DOI: 10.3389/fphar.2017.00465.
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.
Zhang L, Shay J
J Natl Cancer Inst. 2017; 109(8).
PMID: 28423402
PMC: 5963831.
DOI: 10.1093/jnci/djw332.
Interacting partners of FEN1 and its role in the development of anticancer therapeutics.
Kathera C, Zhang J, Janardhan A, Sun H, Ali W, Zhou X
Oncotarget. 2017; 8(16):27593-27602.
PMID: 28187440
PMC: 5432360.
DOI: 10.18632/oncotarget.15176.
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.
Schell M, Yang M, Teer J, Lo F, Madan A, Coppola D
Nat Commun. 2016; 7:11743.
PMID: 27302369
PMC: 4912618.
DOI: 10.1038/ncomms11743.
Interaction between APC and Fen1 during breast carcinogenesis.
Narayan S, Jaiswal A, Law B, Kamal M, Sharma A, Hromas R
DNA Repair (Amst). 2016; 41:54-62.
PMID: 27088617
PMC: 4851606.
DOI: 10.1016/j.dnarep.2016.04.003.
Molecular biology of gynecological cancer.
Sonoda K
Oncol Lett. 2016; 11(1):16-22.
PMID: 26834851
PMC: 4727069.
DOI: 10.3892/ol.2015.3862.
The Ran Pathway in Drosophila melanogaster Mitosis.
Chen J, Barker A, Wakefield J
Front Cell Dev Biol. 2015; 3:74.
PMID: 26636083
PMC: 4659922.
DOI: 10.3389/fcell.2015.00074.
Correlation between mutations and mRNA expression of APC and MUTYH genes: new insight into hereditary colorectal polyposis predisposition.
Aceto G, Fantini F, De Iure S, Di Nicola M, Palka G, Valanzano R
J Exp Clin Cancer Res. 2015; 34:131.
PMID: 26511139
PMC: 4625907.
DOI: 10.1186/s13046-015-0244-4.
Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.
Narayan S, Sharma R
Life Sci. 2015; 139:145-52.
PMID: 26334567
PMC: 4604609.
DOI: 10.1016/j.lfs.2015.08.019.
Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis.
Bonsignore L, Butler J, Klinge C, Schaner Tooley C
Oncotarget. 2015; 6(14):12248-63.
PMID: 25909287
PMC: 4494936.
DOI: 10.18632/oncotarget.3653.